Graphano Energy Ltd. is pleased to announce that, subject to acceptance by the TSX Venture Exchange , it intends to amend the exercise price of 12,334,240 common share purchase warrants . The Warrants ...
ZYUS Life Sciences Corporation (the "Company") , a clinical stage life sciences company focused on the development and commercialization of novel non-opioid pharmaceutical drug candidates for pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results